Header Logo

Lauren Dockery

Concepts (69)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Neoplasm Recurrence, Local
5
2026
337
1.600
 Why?
Ovarian Neoplasms
7
2026
595
1.430
 Why?
Uterine Cervical Neoplasms
2
2022
301
1.070
 Why?
Endometrial Neoplasms
2
2025
189
0.860
 Why?
Vulvar Neoplasms
1
2021
25
0.680
 Why?
Poly(ADP-ribose) Polymerase Inhibitors
2
2020
38
0.680
 Why?
Carcinoma in Situ
1
2021
46
0.670
 Why?
Disease Management
1
2021
90
0.650
 Why?
Platinum Compounds
1
2019
14
0.630
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2022
414
0.570
 Why?
Patient Navigation
1
2018
8
0.570
 Why?
United States Indian Health Service
1
2018
16
0.560
 Why?
Phthalazines
1
2017
25
0.540
 Why?
Piperazines
1
2017
50
0.530
 Why?
Neoplasms, Glandular and Epithelial
1
2017
72
0.520
 Why?
Antineoplastic Agents
1
2019
681
0.420
 Why?
Indians, North American
1
2018
534
0.410
 Why?
Female
11
2026
15471
0.350
 Why?
Bevacizumab
2
2022
106
0.330
 Why?
Aged
6
2026
5525
0.300
 Why?
Molecular Targeted Therapy
2
2020
137
0.290
 Why?
Humans
11
2026
28581
0.250
 Why?
Retrospective Studies
4
2024
2612
0.250
 Why?
Aged, 80 and over
3
2025
2045
0.250
 Why?
Granulosa Cell Tumor
1
2026
4
0.250
 Why?
CD47 Antigen
1
2025
4
0.230
 Why?
CD40 Antigens
1
2025
14
0.230
 Why?
Machine Learning
1
2025
91
0.210
 Why?
Middle Aged
5
2026
7310
0.210
 Why?
Neoadjuvant Therapy
1
2024
74
0.210
 Why?
Prealbumin
1
2022
4
0.200
 Why?
Endometrium
1
2022
39
0.190
 Why?
Cervix Uteri
1
2022
65
0.180
 Why?
Adult
4
2026
7922
0.180
 Why?
Indoles
1
2022
110
0.170
 Why?
Vulvar Lichen Sclerosus
1
2021
1
0.170
 Why?
Vulva
1
2021
5
0.170
 Why?
Papillomaviridae
1
2021
89
0.170
 Why?
Indazoles
1
2020
18
0.170
 Why?
Fallopian Tube Neoplasms
1
2020
53
0.160
 Why?
Piperidines
1
2020
48
0.160
 Why?
Peritoneal Neoplasms
1
2020
80
0.160
 Why?
Papillomavirus Infections
1
2021
147
0.150
 Why?
Disease-Free Survival
1
2019
236
0.150
 Why?
Clinical Trials, Phase II as Topic
1
2017
25
0.140
 Why?
Patient Compliance
1
2018
76
0.140
 Why?
Clinical Trials, Phase I as Topic
1
2017
27
0.140
 Why?
Disease Progression
1
2019
475
0.140
 Why?
Treatment Outcome
2
2020
2402
0.130
 Why?
Randomized Controlled Trials as Topic
1
2017
389
0.120
 Why?
Age Factors
1
2017
734
0.120
 Why?
Risk Factors
1
2021
2111
0.120
 Why?
Prospective Studies
1
2017
1272
0.110
 Why?
United States
1
2018
2201
0.090
 Why?
Young Adult
1
2018
2804
0.080
 Why?
Adolescent
1
2018
3165
0.080
 Why?
Immunoglobulin Fc Fragments
1
2025
5
0.060
 Why?
Recombinant Fusion Proteins
1
2025
233
0.050
 Why?
Drug Resistance, Neoplasm
1
2025
170
0.050
 Why?
Interleukin-8
1
2022
45
0.050
 Why?
Cytoreduction Surgical Procedures
1
2022
33
0.050
 Why?
Vitamin D
1
2022
51
0.050
 Why?
Chemotherapy, Adjuvant
1
2022
113
0.050
 Why?
Predictive Value of Tests
1
2024
480
0.050
 Why?
Interleukin-6
1
2022
194
0.040
 Why?
Pilot Projects
1
2022
458
0.040
 Why?
Biomarkers
1
2022
770
0.040
 Why?
Prognosis
1
2020
807
0.040
 Why?
Postoperative Complications
1
2022
631
0.030
 Why?
Dockery's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (69)
Explore
_
Co-Authors (24)
Explore
_
Similar People (59)
Explore
_
Same Department Expand Description
Explore
_